Relationships Among Serum Pepsinogen I, Serum Pepsinogen II, and Gastric Mucosal Histology

Size: px
Start display at page:

Download "Relationships Among Serum Pepsinogen I, Serum Pepsinogen II, and Gastric Mucosal Histology"

Transcription

1 GASTROENTEROLOGY 1982;83:204-9 Relationships Among Serum Pepsinogen I, Serum Pepsinogen II, and Gastric Mucosal Histology A Study in Relatives of Patients with Pernicious Anemia I. MICHAEL SAMLOFF, KALLE VARIS, TIMO IHAMAKI, MAX SIURALA, and JEROME I. ROTTER Research and Medical Services, Veterans Administration Medical Center, Sepulveda, California; Second Department of Medicine, University of Helsinki, Helsinki, Finland; and Departments of Medicine, Harbor-UCLA Medical Center. Torrance, and UCLA School of Medicine, Los Angeles. California To examine the possible effect of gastritis on the endocrine component of pepsinogen secretion, we determined relationships among gastric mucosal histologic characteristics and serum levels of pepsinogen I and pepsinogen II in 170 first-degree relatives of patients with pernicious anemia. Sixtyfour had normal fundic gland mucosa, 66 had superficial gastritis, 17 had mild or moderate atrophic gastritis, and 23 had severe atrophic gastritis. In superficial gastritis, serum pepsinogen I and pepsinogen II were both significantly higher than normal, but the percentage rise in pepsinogen II was significantly greater than the rise in pepsinogen I. In mild/ moderate atrophic gastritis, pepsinogen I did not differ from normal, but pepsinogen II was significantly ele vated, while in severe atrophic gastritis, pepsinogen II did not differ from normal, but pepsinogen I was significantly decreased. The nonparallel changes in serum pepsinogen I and pepsinogen II levels resulted in a decrease in the pepsinogen I to pepsinogen II ratio from 6.2 ± 0.2 in subjects with normal fundic gland mucosa to 4.3 ± 0.2,2.9 ± 0.4, and 0.7 ± 0.2, respectively, in those with superficial gastritis, mild to moderate atrophic gastritis, and Received October 9, Accepted February 22, Address requests for reprints to: 1. Michael Samloff, M.D., Research Service (151), Veterans Administration Medical Center, Plummer Street, Sepulveda. California This work was supported by Research Grant AM Cent er Grant AM and Clinical Investigator Award AM from the National Institutes of Health, Bethesda. Maryland and by grants from the Yrjo [ahnsson Foundation and Dumex Ltd by the American Gastroenterological Association /8 2/ $02.50 severe atrophic gastritis. The pepsinogen I to pepsinogen II ratio in combination with the absolute level of serum pepsinogen I correctly predicted the histologic status of the gastric mucosa in 119 of the 170 subjects, 70.0%. The results indicate that (a) increasing severity of gastritis is associated with nonparallel alterations in serum levels of pepsinogen I and pepsinogen II, (bj that these changes lead to a progressive decrease in the pepsinogen I to pepsinogen II ratio, and (c) that the pepsinogen I to pepsinogen II ratio, in combination with pepsinogen I, is predictive of the histologic status of the gastric mucosa. We have recently described the development of a radioimmunoassay for pepsinogen II (PG II) and an improved radioimmunoassay for pepsinogen I (PG I), and have reported on the relationship between serum levels of PG I and PG II in healthy control subjects and in patients with pernicious anemia (1). Of particular interest was the finding that pernicious anemia is associated with a significant decrease in serum PG I and a normal level of serum PG II. It is known from results of previous studies that PG II is derived from the pyloric glands in the gastric antrum and from the chief and mucus neck cell components of the fundic glands in the gastric body (2), while PG I is derived only from the fundic glands (3). It is also known that the loss offundic glands in pernicious anemia is associated with preservation of the pyloric glands in the gastric antrum (4,5) and with pyloric gland metaplasia of the proximal stomach (4-6), and it has been reported that metaplastic

2 July 1982 SERUM PEPSINOGENS I AND II IN GASTRITIS 205 pyloric glands contain PG II (7). Thus, we attributed the marked decrease in serum PG I in pernicious anemia to the loss of fundic glands and the normal level of serum PG II to an increase in the mass of pyloric glands (1). If this proposal were correct, one would anticipate that less severe forms of chronic gastritis, which are also associated with a loss of fundic glands, and expansion of the pyloric gland area (8-10), might also produce nonparallel changes in serum levels of PG I and PG II. Specifically, our hypothesis was that increasing severity of chronic gastritis of the fundic gland mucosa would result in a progressive decrease in the ratio of PG I to PG II in serum. The results of this study support this hypothesis and indicate that the PG IIPG II ratio in combination with the absolute level of PG I is predictive of the histologic status of the gastric mucosa. Materials and Methods Subjects The original subject population consisted of 183 first-degree relatives of 68 probands with pernicious anemia who had participated in an endoscopic biopsy study of the prevalence of chronic gastritis in family members of patients with pernicious anemia. Data on gastric morphologic characteristics and gastric acid output in this population have been reported previously (4). Serum was available for the determination of PG I and PG II in 173 of the 175 relatives who had biopsies of fundic and pyloric gland mucosa and from 62 probands. Of the 173 relatives, three were excluded from analysis because an elevated serum PG I level was associated with a high serum urea nitrogen level (11). The 170 subjects who form the basis of this report consisted of 72 men and 98 women ranging in age from 15 to 87 yr old. None had clinical symptoms suggestive of peptic ulcer disease and none were found to have an ulcer at endoscopy. Gastric peak acid output had been determined in response to pentagastrin, 6 JLg/kg body wt, in 169 subjects. Gastric morphologic characteristics had been ascertained from endoscopic biopsies of the midbody and antrum. The median number of biopsy specimens obtained from each site was 6 (range 2-12) and 3 (range 1-7), respectively. The histologic status of each biopsy specimen had been classified without knowledge of the secretory or serologic data. Subjects with nonconcordant biopsy specimens were assigned to a histologic category based on the average of all specimens or if two categories were represented equally to the more severe. Sixty-four subjects had normal fundic gland mucosa and 55 of these also had normal pyloric gland mucosa. There were 66 subjects with superficial gastritis of the body mucosa, only three of whom had normal pyloric gland mucosa. The pyloric gland mucosa was normal in five of 17 subjects with mild or moderate atrophic gastritis and in 17 of 23 subjects with severe atrophic gastritis of the fundic gland mucosa. Serum Pepsinogens I and II Serum PG I and PG II levels were determined by specific radioimmunoassays using reference standards that had been prepared from gastric mucosa (1). Statistical Tests The significance of differences in mean values between histologic groups was determined by Student's t test for unpaired samples and the equality of proportions was tested by z-approximation (12). In all analyses, mild and moderate atrophic gastritis were combined because the latter category included only four subjects. Discriminant Function Analysis To determine the ability of each test to predict the histologic status of the gastric mucosa, discriminant values were generated by computer using established statistical programs (13,14). For this purpose, serum PG I, serum PG II, and their derived values were normalized by square root transformation. The discriminant value of each test was used to calculate its sensitivity (percentage of subjects with the specified trait who have a positive test), specificity (percentage of subjects without the trait who have a negative test), positive predictive value (percentage of subjects with a positive test who have the trait), negative predictive value (percentage of subjects with a negative test who do not have the trait), and efficiency (percentage of subjects correctly ascertained by positive and negative test results). For the simultaneous assignment of all subjects to each histologic category, only sensitivity and positive predictive value could be calculated. Results Pepsinogen I, Pepsinogen II, and Gastric Mucosal Histology Mean (±SE) levels of serum PG I and PG II in the subjects with normal fundic gland mucosa were 66.3 ± 3.2 and 11.1 ± 0.5 ng/ml, respectively. Total immunoreactive serum pepsinogen (TISP) was 77.4 ± 3.6 ng/ml and the PG IIPG II ratio was 6.2 ± 0.2. The distribution of values for the PG IIPG II ratio is shown in Figure 1. Mean TISP in the subjects with superficial gastritis was significantly higher than in those with normal fundic gland mucosa due to significant increases in serum PG I and PG II (Table 1). The rise in PG II, as a percentage of normal, was 91%,while the rise in PG I was only 30%. This resulted in a significant fall in the PG IIPG II ratio to 4.3 ± 0.1. Within the group of subjects with superficial gastritis, the PG IIPGII ratio was 4.5 ± 0.2 in those with mild involvement and 3.5 ± 0.5 in those with severe involvement (Figure 1). Both values differed significantly from normal, but not from each other.

3 206 SAMLOFF ET AL. GASTROENTEROLOGY Vol. 83. No.1. Part 2 Figure 1. Distribution of values for the PG IIPG II ratio according to the hi stologic status of the fundic gland mu cosa. The symbols indicate mean ± SE o ~ o I - I t".., If ~f - t I.. NORMAL N'28 -N-'2"'-j- -N-'"-- --N-.1-7-* ~ N'62 MILD MODERATE SEVERE MILD MOO. SEVERE PERNICIOUS SUPERFICIAL GASTRITIS ATROPHIC GASTRITIS ANEMIA I I CASE o.10 CASES Serum PG I was lower than normal in the subjects with mild to moderate atrophic gastritis, but the difference was not statistically significant. Serum PG II, however, was significantly higher than normal (Table 1). The PG I1PG II ratio was 2.9 ± 0.4, significantly less than in normal subjects and in subjects with superficial gastritis. Serum PG I was significantly lower than normal in the subjects with severe atrophic gastritis, but serum PG II did not differ from normal. This led to a further decrease in the PG I/PG II ratio to 0.7 ± 0.2 (Table 1). The values for serum PG I, serum PG II, TISP, and the PG I/PG II ratio in the patients with pernicious anemia were all lower than in the subjects with severe atrophic gastritis, but none of the differences were statistically significant (Table 1). With the exception of serum PG II, all values were significantly lower than normal. Age and Sex Mean levels of serum PG I and PG II did not differ significantly in men and women matched for the same histologic status of the gastric body mucosa. The PG I1PG II ratio was 5.2 ± 0.2 in subjects who were 50 yr of age or less and 3.0 ± 0.2 in those over age 50 yr (p < 10-5 ). This was attributable to an increase in the prevalence of atrophic gastritis from 13.8% to 37.7% (p < 10-3 ) in the respective age groups. Gastric Acid Output The mean level of gastric peak acid output in each histologic category paralleled the change in the PG I/PG II ratio (Table 1). Table 1. Mean (±SE) Levels of Serum Pepsinogen I (PG I), Serum Pepsinogen II (PG II), Total Immunoreactive Serum Pep sinogen (TISP), PG IIPG II Ratio, and Peak A cid Output Peak Histology Serum Serum acid of fundic PG I PG II TISP PG IIPG II output gland mucosa (ng/ml) (ng/rnl] [ng/ml] ratio (rnmol/h] Normal mu cosa 66.3 ± ± ± ± ± 1.6 Superficial gastritis 86.5 ± 4.6 b 21.2 ± 1.2 c ± 5.6 c 4.3 ± 0.2 c 23.3 ± 1.6 U Mild to mo derate atr ophic gastr itis 55.5 ± 8.6 x 18.2 ± 1.6 c 73.7 ± 9.6 x 2.9 ± 0.4 c x 6.1 ± 1.6 d z Severe atr oph ic gastritis 9.6 ± 2.2 d,z 12.5 ± 1.1 x 22.1 ± 2.9 d,z 0.7 ± 0,2 d,z 0.4 ± o.a-> Pernicious ane mia 4.8 ± 0.6 d 10.2 ± ± 1.0 d 0.5 ± 0.1< O.Od Signi fican ce of difference from normal: up < 10-2 bp < 10-3 "p < 10-4 d p < 10-5, Signi fican ce of difference from preceding value: xp < 10-2, Yp < 10-3, zp < 10-4

4 July 1982 SERUM PEPSINOGENS I AND II IN GASTRITIS 207 Table 2. Classification Matrix of Gastric Mucosal Histology by Pepsinogen I/Pepsinogen II Ratio in Combination with Pepsinogen I Classification by PG IIPG II ratio and PG I Mild to moderate Severe Classification Normal Superficial atrophic atrophic by biopsy No. mucosa gastritis gastritis gastritis Normal mucosa Superficial gastritis Mild to moderate atrophic gastritis Severe atrophic gastritis Discriminant Function Analysis Discriminant function analysis revealed that the PG I/PG II ratio in combination with the absolute level of PG I had a higher sensitivity and positive predictive value for the morphologic status of the fundic gland mucosa than the ratio alone. This combination correctly assigned 119 (70.0%) of the 170 subjects (Table 2). When classification was made by gastric peak acid output, 86 (50.9%) of 169 subjects were assigned to the correct histologic category (Table 3). A comparison of Table 2 and Table 3 reveals that the combined determination of PG I and PG II was better able to predict normal mucosa and superficial gastritis than peak acid output, but that they did not differ in their ability to predict atrophic gastritis. The operational characteristics of the PG I/PG II ratio in combination with the level of PG I were also better than those for the ratio alone in distinguishing between subjects with and without normal fundic mucosa. In this instance, the sensitivity for normal mucosa was 87.5% and the positive predictive value was 77.8% (Table 4). The respective values for peak acid output were 67.2% and 57.3%. Discussion This study has shown that in subjects with normal fundic gland mucosa the concentration of PG I in serum is about six times higher than that of PG II. This finding implies that the rate of endocrine release of PG I from the chief cells is greater than the rate of release of PG II from both the chief cells and the pyloric glands or that PG I has a longer metabolic clearance rate than PG II. There is no information about the clearance rates of PG I and PG II, but it has been reported that the ratio of the concentrations of PG I and PG II in fundic gland mucosa and PG II in pyloric gland mucosa is in the order of 9:3:1 (15). Thus, there is reason to suppose that the higher concentration of PG I in serum is due, at least in part, to a higher rate of synthesis and release of this zymogen into the circulation. Since the fundic gland area of the stomach is normally larger than the pyloric gland area and contains a higher concentration of PG II (15), there is also reason to suppose that the chief cells are normally the major source of circulating PG II. A diagrammatic representation of the relationships found among nsp, PG I, and PG II in the 64 subjects with normal fundic gland mucosa Table 3. Classification Matrix of Gastric Mucosal Histology by Peak Acid Output Classification by peak acid output Mild to moderate Severe Classification Normal Superficial atrophic atrophic by biopsy No. mucosa gastritis gastritis gastritis Normal mucosa Superficial gastritis Mild to moderate atrophic gastritis Severe atrophic gastritis

5 208 SAMLOFF ET AL. GASTROENTEROLOGYVol. 83, No.1, Part 2 Table 4. Discriminant Values of Tests and Their Operational Characteristics for Normal Gastric Mucosa Discriminant Sensitivity Specificity PVpos" PVNeg b Efficiency Test value (%) (%) (%) (%) (%) TISpc <74.4 ng/ml Serum PG I d >62.0 ng/ml PAO e >22.8 mmol/h Serum PG lit <14.0 ng/ml PG IIPG II ratio > PG IIPG II & PG Ig a Positive predictive value. b Negative predictive value. C Total immunoreactive serum pepsinogen. d Pepsinogen I. e Peak acid output. t Pepsinogen II. g Discriminant value for the combination: 5.49YPG IIPG II YPG I >5.60. is shown in Figure 2A. The values shown for the fundic and pyloric gland components of serum PG II were calculated on the assumption that 80% of total serum PG II is normally derived from the fundic glands and 20% is derived from the pyloric glands. These are hypothetical values for the purpose of discussion. Superficial gastritis of the fundic gland mucosa was associated with significant increases in serum PG I and PG II, but the rise in serum PG II, as a percentage of normal, was about threefold greater than that of PG I. These changes could be due to a greater increase in the rate of release of PG II than PG I from the chief cells or to an increased rate of PG II release from the pyloric glands and an increased but parallel rate of PG I and PG II release from the chief cells. The latter hypothesis is consistent with the observation that all but three subjects with superfi- Figure 2. Diagrammatic representation of relationships among total immunoreactive serum pepsinogen (TISP), serum pepsinogen I (PG I), serum pepsinogen II (PG II), and gastric mucosal histologic characteristics. The area of each circle is proportional to the level of total immunoreactive serum pepsinogen. The mean levels of serum PG I and PG II found in each histologic category are shown within their respective segments. Each PG II segment is divided by a dashed line into fundic and pyloric gland components. The numbers adjacent to the fundic and pyloric gland components were derived as follows: A. The values were calculated on the premise that the fundic gland contribution to serum PG II is normally four times greater than that of the pyloric glands; B, C and D. The values for the fundic gland component of serum PG II were calculated on the premise that a change in serum PG I, as a percentage of normal, is associated with a parallel percentage change in the fundic gland contribution to serum PG II. The values for the pyloric gland component of serum PG II were calculated by subtracting the fundic gland component from total serum PG II. TISP (no/mil PGIIPGII RATIO NORMAL LD/MODERATE ATROPHIC GASTRITIS TlSP (no/ml) PGIIPGII RATIO SUPERFICIAL GASTRITIS D SEVERE ATROPHIC GASTRITIS o PGI [i) Fundic PGll rn Pyloric PGlI

6 July 1982 SERUM PEPSINOGENS I AND II IN GASTRITIS 209 cial gastritis of the gastric body mucosa also had antral gastritis. Since the percentage rise in serum PG I above normal was 30%, the model for this hypothesis (Figure 2B) attributes 30% of the observed increase in serum PG II to the chief cells and 70% to the pyloric glands. The small decrease in serum PG I and the persistent and significant increase in serum PG II in mild to moderate atrophic gastritis can be explained by extending the general concepts developed for superficial gastritis as follows: (a) The chief cells, although reduced in number, continue to release PG I into the circulation at an increased rate due to the surrounding inflammatory changes. The net result is a modest reduction in serum PG I. (b) The inflammatory changes in the antral mucosa, which were found in most of these subjects, together with an increase in the number of pyloric glands due to pyloric gland metaplasia results in an elevation in serum PG II. The model for this proposal (Figure 2C), in concert with the one proposed for superficial gastritis (Figure 2B), assumes a parallel rate of PG I and PG II release from the chief cells. Thus, the calculated value for the fundic gland contribution to circulating PG II is less than normal. The marked fall in serum PG I and the return of serum PG II to normal in severe atrophic gastritis can be explained by the marked loss of fundic glands and a further increase in the number of pyloric glands. The calculated values for the fundic and pyloric gland contributions to total serum PG II are shown in Figure 2D. The results of previous endoscopic biopsy studies suggest that the topology of gastritis in relatives of patients with pernicious anemia is similar to that found in other populations (16,17). For example, in a study of 50 healthy volunteers, Kreuning et al. (17) found only two with gastritis limited to one mucosal area; both gland areas were abnormal in 16 and both were normal in 32 subjects. Since a determinant of the PG I/PG II ratio appears to be the topology of gastritis, there is reason to suppose that the results of this investigation may be applicable to other populations. Preliminary results in a control population support this proposal (18). Discriminant function analysis revealed that the expression of serum PG I and PG II that best correlated with the histologic status of the fundic gland mucosa was the PG I/PG II ratio in combination with the absolute level of serum PG I. For the simultaneous assignment of all subjects, the overall sensitivity and positive predictive value of this combination was 70%, i.e., 119 of the 170 subjects were classified correctly. This was significantly higher (p < 0.005) than the value for peak acid output, which was only 51%. For the dichotomous assignment, normal vs. any degree of gastritis, the combined determination of serum PG I and PG II had a sensitivity of 87.5% and a positive predictive value of 77.8%. The corresponding values for peak acid output were again about 20% lower. These observations suggest that the combined determination of serum PG I and PG II provide a "serologic biopsy" of the fundic gland mucosa. As such, they may be useful for studies of the genetic, immunologic, epidemiologic, and clinical correlates of chronic gastritis. References 1. Samloff 1M. Pepsinogens I and II. Purification from gastric mucosa and radioimmunoassay in serum. Gastroenterology 1981;82: Samloff 1M,Liebman WM. Cellular localization of the group II pepsinogens in human stomach and duodenum by immunofluorescence. Gastroenterology 1973;65: Samloff 1M. Cellular localization of group I pepsinogens in human gastric mucosa by immunofluorescence. Gastroenterology 1971;61: Varis K, Ihamaki T, Harkonen M, et al. Gastric morphology, function, and immunology in first-degree relatives of probands with pernicious anemia and controls. Scand J Gastroenterol 1979;14: Siurala M, Eramaa E, Nyberg W. Pernicious anemia and atrophic gastritis. Acta Med Scand 1960;166: Lewin KJ, Sawling F, Wright JR, et al. Gastric morphology and serum gastrin levels in pernicious anemia. Gut 1976;17: Lechago J, Black C, Samloff 1M. Immunofluorescence studies of gastric heterotopia of the small intestine in Crohn's disease. Gastroenterology 1976;70: Kimura K. Chronological transition of the fundic-pyloric border determined by stepwise biopsy of the lesser and greater curvatures of the stomach. Gastroenterology 1972; 63: Whitehead R. Mucosal biopsy of the gastrointestinal tract. Philadelphia: W. B. Saunders, Siurala M, Isokoski M, Varis K, et al. Prevalence of gastritis in a rural population. Bioptic study of subjects selected at random. Scand J GastroenteroI1968;3: Samloff 1M, Liebman WM, Panitch NM. Serum group I pepsinogens by radioimmunoassay in control subjects and patients with peptic ulcer. Gastroenterology 1975;69:83..., Dixon WI. Massey SJ, Jr. Introduction to statistical analysis. 3rd ed. New York: McGraw Hill, Afifi AA, Azen SP. Statistical analysis. A computer oriented approach. New York: Academic Press, Dixon WI. Brown MB. BMDP-77, Biomedical computer programs P-series. Berkeley: University of California Press, Libman LJ, Samloff 1M. Quantitative distribution of pepsinogens I and II in gastric mucosa (abstr). Gastroenterology 1978;74: Ihamaki T, Kekki M, Varis K, et al. Family patterns of antrofundal gastritis. Acta Hepatogastroenterol 1976;23: Kreuning I. Bosman FT, Kuiper G, et al. Gastric and duodenal mucosa in "healthy" individuals. An endoscopic study of 50 volunteers. J Clin Pathol1978;31: Samloff 1M,Varis K, Ihamaki T, et al. Determination of gastric mucosal histology by serological and secretory tests (abstr). Gastroenterology 1981;80:1269.

Elevated Serum Pepsinogen I and II Levels Differ as Risk Factors for Duodenal Ulcer and Gastric Ulcer

Elevated Serum Pepsinogen I and II Levels Differ as Risk Factors for Duodenal Ulcer and Gastric Ulcer GASTROENTEROLOGY 1986;90:570-6 Elevated Serum Pepsinogen I and II Levels Differ as Risk Factors for Duodenal Ulcer and Gastric Ulcer I. MICHAEL SAMLOFF, GRANT N. STEMMERMANN, LANCE K. HEILBRUN, and ABRAHAM

More information

Update on the pathological classification of gastritis. Hala El-Zimaity, M.D. M.S. Epidemiology McMaster University Hamilton, Ontario Canada

Update on the pathological classification of gastritis. Hala El-Zimaity, M.D. M.S. Epidemiology McMaster University Hamilton, Ontario Canada Update on the pathological classification of gastritis Hala El-Zimaity, M.D. M.S. Epidemiology McMaster University Hamilton, Ontario Canada CLASSIFICATION GASTRITIS GASTROPATHY 1. Acute 2. Chronic 3. Uncommon

More information

Clinical Study Multifaceted Assessment of Chronic Gastritis: A Study of Correlations between Serological, Endoscopic, and Histological Diagnostics

Clinical Study Multifaceted Assessment of Chronic Gastritis: A Study of Correlations between Serological, Endoscopic, and Histological Diagnostics Gastroenterology Research and Practice Volume 2, Article ID 6346, 7 pages doi:.55/2/6346 Clinical Study Multifaceted Assessment of Chronic Gastritis: A Study of Correlations between Serological, Endoscopic,

More information

Case Report Features of the Atrophic Corpus Mucosa in Three Cases of Autoimmune Gastritis Revealed by Magnifying Endoscopy

Case Report Features of the Atrophic Corpus Mucosa in Three Cases of Autoimmune Gastritis Revealed by Magnifying Endoscopy Volume 2012, Article ID 368160, 4 pages doi:10.1155/2012/368160 Case Report Features of the Atrophic Corpus Mucosa in Three Cases of Autoimmune Gastritis Revealed by Magnifying Endoscopy Kazuyoshi Yagi,

More information

HISTOPATHOLOGICAL STUDY OF ENDOSCOPIC BIOPSIES OF STOMACH

HISTOPATHOLOGICAL STUDY OF ENDOSCOPIC BIOPSIES OF STOMACH HISTOPATHOLOGICAL STUDY OF ENDOSCOPIC BIOPSIES OF STOMACH Pages with reference to book, From 177 To 179 Javed Iqbal Kazi, Syed Mahmood Alam ( Departments of Pathology, Jinnah Postgraduate Medical Centre,

More information

Cutoff Serum Pepsinogen Values for Predicting Gastric Acid Secretion Status

Cutoff Serum Pepsinogen Values for Predicting Gastric Acid Secretion Status Tohoku J. Exp. Med., 2014, 232, 293-300 Serum PG and Gastric Acid Secretion 293 Cutoff Serum Pepsinogen Values for Predicting Gastric Acid Secretion Status Katsunori Iijima, 1 Tomoyuki Koike, 1 Yasuhiko

More information

Overview of digestion or, gut reactions - to food

Overview of digestion or, gut reactions - to food Key concepts in Digestion. Indigestion module Overview of digestion or, gut reactions - to food Prof. Barry Campbell Gastroenterology Cellular & Molecular Physiology e-mail: bjcampbl@liv.ac.uk http://pcwww.liv.ac.uk/~bjcampbl

More information

Overview of digestion or, gut reactions - to food

Overview of digestion or, gut reactions - to food 1 Key concepts in Digestion. Indigestion module Overview of digestion or, gut reactions to food Prof. Barry Campbell Gastroenterology Cellular & Molecular Physiology email: bjcampbl@liv.ac.uk http://pcwww.liv.ac.uk/~bjcampbl

More information

Gastrin cells and fasting serum gastrin levels in duodenal ulcer patients A quantitative study based on multiple biopsy specimens

Gastrin cells and fasting serum gastrin levels in duodenal ulcer patients A quantitative study based on multiple biopsy specimens Journal of Clinical Pathology, 1979, 32, 171-178 Gastrin cells and fasting serum gastrin levels in duodenal ulcer patients A quantitative study based on multiple biopsy specimens JUAN PIRIS AND R. WHITEHEADI

More information

A Study of the Correlation between Endoscopic and Histological Diagnoses in Gastroduodenitis

A Study of the Correlation between Endoscopic and Histological Diagnoses in Gastroduodenitis 000-9 70/8 7/80S-0749 THE AMERICAN JOIIRNAE. OF GAsrR()E.NrER 1987 by Am. Coll.ofGastroenterology Vo!.8. No. 8, 1487 Printed in U.S.A. A Study of the Correlation between Endoscopic

More information

(b) Stomach s function 1. Dilution of food materials 2. Acidification of food (absorption of dietary Fe in small intestine) 3. Partial chemical digest

(b) Stomach s function 1. Dilution of food materials 2. Acidification of food (absorption of dietary Fe in small intestine) 3. Partial chemical digest (1) General features a) Stomach is widened portion of gut-tube: between tubular and spherical; Note arranged of smooth muscle tissue in muscularis externa. 1 (b) Stomach s function 1. Dilution of food

More information

Association of Helicobacter pylori infection with Atrophic gastritis in patients with Dyspepsia

Association of Helicobacter pylori infection with Atrophic gastritis in patients with Dyspepsia ADVANCES IN BIORESEARCH Adv. Biores., Vol 8 [3] May 2017: 137-141 2017 Society of Education, India Print ISSN 0976-4585; Online ISSN 2277-1573 Journal s URL:http://www.soeagra.com/abr.html CODEN: ABRDC3

More information

594 Lewin, Weinstein, and Riddell s Gastrointestinal Pathology and Its Clinical Implications

594 Lewin, Weinstein, and Riddell s Gastrointestinal Pathology and Its Clinical Implications 594 Lewin, Weinstein, and Riddell s Gastrointestinal Pathology and Its Clinical Implications Figure 13-20. Stages in the natural history of H. pylori. Biopsies from the antrum are on the left and the oxyntic

More information

Clinical importance of Campylobacter pyloridis and associated serum IgG and IgA antibody responses in

Clinical importance of Campylobacter pyloridis and associated serum IgG and IgA antibody responses in J Clin Pathol 1986;39:215-219 Clinical importance of Campylobacter pyloridis and associated serum IgG and IgA antibody responses in patients undergoing upper gastrointestinal endoscopy LINDA BOOTH, G HOLDSTOCK,

More information

Noninvasive Versus Histologic Detection of Gastric Atrophy in a Hispanic Population in North America

Noninvasive Versus Histologic Detection of Gastric Atrophy in a Hispanic Population in North America CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2006;4:306 314 Noninvasive Versus Histologic Detection of Gastric Atrophy in a Hispanic Population in North America DAVID Y. GRAHAM,* ZHANNAT Z. NURGALIEVA,* HALA

More information

Campylobacter pylori in non-specific abdominal pain in childhood

Campylobacter pylori in non-specific abdominal pain in childhood Gut, 1989, 3, 912-916 Serum pepsinogen I and IgG antibody to Campylobacter pylori in non-specific abdominal pain in childhood GIUSEPPINA ODERDA, D VAIRA, J HOLTON, J F DOWSETT, AND NICOLETTA ANSALDI From

More information

Fundic Gland Polyposis in Patients Without Familial Adenomatosis Coli: Its Incidence and Clinical Features

Fundic Gland Polyposis in Patients Without Familial Adenomatosis Coli: Its Incidence and Clinical Features GASTROENTEROLOGY 1984;86;1437-42 ALIMENTARY TRACT Fundic Gland Polyposis in Patients Without Familial Adenomatosis Coli: Its Incidence and Clinical Features MITSUO IIDA, TSUNEYOSHI YAO, HIDENOBU WATANABE,

More information

Atrophic gastritis and vitamin C status in two towns with different stomach cancer death-rates

Atrophic gastritis and vitamin C status in two towns with different stomach cancer death-rates Br. J. Cancer (1987), 56, 163-167 (B1) The Macmillan Press Ltd., 1987 Atrophic gastritis and vitamin C status in two towns with different stomach cancer death-rates M.L. Burr", I.M. Samloff2, C.J. Bates3

More information

Our gut reactions to food or, gut reactions - to food

Our gut reactions to food or, gut reactions - to food Key concepts in Digestion. Our gut reactions to food or, gut reactions to food Prof. Barry Campbell Cellular & Molecular Physiology email: bjcampbl@liv.ac.uk http://pcwww.liv.ac.uk/~bjcampbl Swallowing

More information

Gastric Polyps. Bible class

Gastric Polyps. Bible class Gastric Polyps Bible class 29.08.2018 Starting my training in gastroenterology, some decades ago, my first chief always told me that colonoscopy may seem technically more challenging but gastroscopy has

More information

Population studies have shown that the prevalence

Population studies have shown that the prevalence Volume 6 Number 4 2001 HELICOBACTER Blackwell Science Ltd Atrophic Gastritis and Intestinal Metaplasia in Japan: Results of a Large Multicenter Study Masahiro Asaka, * Toshiro Sugiyama, * Aichiro Nobuta,

More information

Histological appearances of the gastric mucosa

Histological appearances of the gastric mucosa Journal of Clinical Pathology, 1979, 32, 179-186 Histological appearances of the gastric mucosa 15-27 years after partial gastrectomy ANN SAVAGE AND S. JONES From the Departments ofpathology and Surgery,

More information

Gastric atrophy: use of OLGA staging system in practice

Gastric atrophy: use of OLGA staging system in practice Gastroenterology and Hepatology From Bed to Bench. 2016 RIGLD, Research Institute for Gastroenterology and Liver Diseases ORIGINAL ARTICLE Gastric atrophy: use of OLGA staging system in practice Mahsa

More information

Helicobacter pylori infection and chronic gastritis

Helicobacter pylori infection and chronic gastritis J Clin Pathol 1992;45:319-323 319 Helicobacter pylori infection and chronic gastritis in gastric cancer Pathology, Jorvi Hospital, 02740 Espoo, P Sipponen J Valle M Riihela Bacteriology and Immunology,

More information

Is there a role for screening gastric carcinoma or preneoplastic lesions?

Is there a role for screening gastric carcinoma or preneoplastic lesions? Is there a role for screening gastric carcinoma or preneoplastic lesions? Mário Dinis-Ribeiro, MD, PhD Instituto Português de Oncologia do Porto, Department of Gastroenterology Faculty of Medicine, University

More information

PATHOLOGY OF NON NEOPLASTIC LESIONS OF THE UPPER GASTROINTESTINAL TRACT.

PATHOLOGY OF NON NEOPLASTIC LESIONS OF THE UPPER GASTROINTESTINAL TRACT. PATHOLOGY OF NON NEOPLASTIC LESIONS OF THE UPPER GASTROINTESTINAL TRACT. OESOPHAGEAL LESIONS OESOPHAGITIS AND OTHER NON NEOPLASTIC DISORDERS Corrosive Gastroesophageal reflux (GERD), Pills, Acid intake,

More information

5. Which component of the duodenal contents entering the stomach causes the most severe changes to gastric mucosa:

5. Which component of the duodenal contents entering the stomach causes the most severe changes to gastric mucosa: Gastro-intestinal disorders 1. Which are the most common causes of chronic gastritis? 1. Toxic substances 2. Chronic stress 3. Alimentary factors 4. Endogenous noxious stimuli 5. Genetic factors 2. Chronic

More information

A HISTOLOGICAL STUDY OF THE EFFECTS OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDs) ON THE GASTRIC AND DUODENAL MUCOSA

A HISTOLOGICAL STUDY OF THE EFFECTS OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDs) ON THE GASTRIC AND DUODENAL MUCOSA A HISTOLOGICAL STUDY OF THE EFFECTS OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDs) ON THE GASTRIC AND DUODENAL MUCOSA Abstract Pages with reference to book, From 287 To 290 Naheed Moghal, N.A. Jafarey

More information

Campylobacter pyloridis and acid induced gastric

Campylobacter pyloridis and acid induced gastric J Clin Pathol 1987;40:841-848 Campylobacter pyloridis and acid induced gastric metaplasia in the pathogenesis of duodenitis J I WYATT,* B J RATHBONE,t M F DIXON,: R V HEATLEYt From the Departments of *Pathology

More information

The surface mucous cells and the cardiac and pyloric glands secrete mucus which protects the stomach from self-digestion.

The surface mucous cells and the cardiac and pyloric glands secrete mucus which protects the stomach from self-digestion. PATHOLOGY OF THE STOMACH Stomach mucosa Gastric mucosa is covered by a layer of mucus. The mucosal glands comprise the cardiac glands, the fundic glands in the fundus and body of the stomach, and the pyloric

More information

University of Buea. Faculty of Health Sciences. Programme in Medicine

University of Buea. Faculty of Health Sciences. Programme in Medicine Faculty of Health Sciences University of Buea Wednesday, 28 th January 2009 Time: 8 00-10 00 Programme in Medicine MED 303 (Gastrointestinal Physiology) EXAMS (2008-2009) Identify the letter of the choice

More information

Helicobacter Pylori Testing HELICOBACTER PYLORI TESTING HS-131. Policy Number: HS-131. Original Effective Date: 9/17/2009

Helicobacter Pylori Testing HELICOBACTER PYLORI TESTING HS-131. Policy Number: HS-131. Original Effective Date: 9/17/2009 Easy Choice Health Plan, Inc. Harmony Health Plan of Illinois, Inc. Missouri Care, Inc. Ohana Health Plan, a plan offered by WellCare Health Insurance of Arizona, Inc. WellCare Health Insurance of Illinois,

More information

Relation between reflux of bile acids into the stomach and gastric mucosal atrophy, intestinal metaplasia in biopsy specimens

Relation between reflux of bile acids into the stomach and gastric mucosal atrophy, intestinal metaplasia in biopsy specimens Original Article JCBN Journal 0912-0009 1880-5086 the Kyoto, jcbn11-90 10.3164/jcbn.11-90 Original Society Japan of Article Clinical for Free Biochemistry Radical Research and Nutrition Japan Relation

More information

GASTRIN CELL DISTRIBUTION IN NORMAL HUMAN STOMACHS AND IN PATIENTS WITH ZOLLINGER-ELLISON SYNDROME

GASTRIN CELL DISTRIBUTION IN NORMAL HUMAN STOMACHS AND IN PATIENTS WITH ZOLLINGER-ELLISON SYNDROME 0016-5085/78/7501-0061$02.00/0 GASTROENTEROLOGY 75:61-65, 1978 Copyright 1978 by the American Gastroenterological Association Vol. 75, No.1 Printed in U.S.A. GASTRIN CELL DISTRIBUTION IN NORMAL HUMAN STOMACHS

More information

PDF hosted at the Radboud Repository of the Radboud University Nijmegen

PDF hosted at the Radboud Repository of the Radboud University Nijmegen PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/48400

More information

Helicobacter and gastritis

Helicobacter and gastritis 1 Helicobacter and gastritis Dr. Hala Al Daghistani Helicobacter pylori is a spiral-shaped gram-negative rod. H. pylori is associated with antral gastritis, duodenal (peptic) ulcer disease, gastric ulcers,

More information

Frontiers of Gastrointestinal Research. The Stomach 6 Editor L.van der Reis. San Francisco. Calif. S. Karger Basel Mnchen Paris London New York Sydney

Frontiers of Gastrointestinal Research. The Stomach 6 Editor L.van der Reis. San Francisco. Calif. S. Karger Basel Mnchen Paris London New York Sydney Frontiers of Gastrointestinal Research The Stomach 6 Editor L.van der Reis. San Francisco. Calif. S. Karger Basel Mnchen Paris London New York Sydney ISBN-3-8055-3071-4 The Stomach Frontiers of Gastrointestinal

More information

~Helicobacter pylori, gastritis, and peptic ulceration

~Helicobacter pylori, gastritis, and peptic ulceration 17 Department of Pathology J I Wyatt Department of Medicine T M Shallcross J E Crabtree RV Heatley St James University Hospital, Leeds LS9 7TF Correspondence to: Dr J I Wyatt. Accepted for publication

More information

KK College of Nursing Peptic Ulcer Badil D ass Dass, Lecturer 25th July, 2011

KK College of Nursing Peptic Ulcer Badil D ass Dass, Lecturer 25th July, 2011 KK College of Nursing Peptic Ulcer Badil Dass, Lecturer 25 th July, 2011 Objectives: By the end of this lecture, the students t will be able to: Define peptic pp ulcer Describe the etiology and pathology

More information

Gastritis and gastric atrophy Hala El-Zimaity a,b

Gastritis and gastric atrophy Hala El-Zimaity a,b Gastritis and gastric Hala El-Zimaity a,b a Department of Pathology, McMaster University, Hamilton, Ontario, Canada and b Department of Medicine, Michael E. DeBakey Veterans Affairs Medical Center, Baylor

More information

SUMMARY INTRODUCTION. Aliment Pharmacol Ther 2000; 14: 625±634. Accepted for publication 20 January 2000

SUMMARY INTRODUCTION. Aliment Pharmacol Ther 2000; 14: 625±634. Accepted for publication 20 January 2000 Aliment Pharmacol Ther 2000; 14: 625±634. Cure of Helicobacter pylori infection in atrophic body gastritis patients does not improve mucosal atrophy but reduces hypergastrinemia and its related effects

More information

Gastric gland metaplasia in the small and

Gastric gland metaplasia in the small and Gut, 1977, 18, 214-218 Gastric gland metaplasia in the small and large intestine I. YOKOYAMA, S. KOZUKA, K. ITO, K. KUBOTA, Y. YOKOYAMA, AND T. KONDO From the Second Department of Surgery and the Second

More information

Prevalence of Multiple White and Flat Elevated Lesions in Individuals Undergoing a Medical Checkup

Prevalence of Multiple White and Flat Elevated Lesions in Individuals Undergoing a Medical Checkup doi: 10.2169/internalmedicine.9808-17 http://internmed.jp ORIGINAL ARTICLE Prevalence of Multiple White and Flat Elevated Lesions in Individuals Undergoing a Medical Checkup Kyoichi Adachi 1, Tomoko Mishiro

More information

Correlations Among Endoscopic, Histologic and Serologic Diagnoses for the Assessment of Atrophic Gastritis

Correlations Among Endoscopic, Histologic and Serologic Diagnoses for the Assessment of Atrophic Gastritis JOURNAL OF CANCER PREVENTION Vol. 19, No. 1, March, 2014 http://dx.doi.org/10.15430/jcp.2014.19.1.47 pissn 2288-3649 ㆍ eissn 2288-3657 Correlations Among Endoscopic, Histologic and Serologic Diagnoses

More information

Correlation between Gastric Mucosal Morphologic Patterns and Histopathological Severity of

Correlation between Gastric Mucosal Morphologic Patterns and Histopathological Severity of Hindawi Publishing Corporation BioMed Research International Volume 2015, Article ID 808505, 7 pages http://dx.doi.org/10.1155/2015/808505 Research Article Correlation between Gastric Mucosal Morphologic

More information

Characteristics of Helicobacter pylorinegative and -positive peptic ulcer disease

Characteristics of Helicobacter pylorinegative and -positive peptic ulcer disease Age and Ageing 1998; 27: 427-43 I 1998, British Geriatrics Society Characteristics of Helicobacter pylorinegative and -positive peptic ulcer disease HELENA KEMPPAINEN, ISMO MIHA, HARRY KUJARI 1, LEIF SOURANDER

More information

GASTRIC HETEROTOPIA IN THE ILEUM WITH ULCERATION AND CHRONIC BLEEDING

GASTRIC HETEROTOPIA IN THE ILEUM WITH ULCERATION AND CHRONIC BLEEDING GASTROENTEROLOGY 66: 113-117, 1974 Copyright 1974 by The Williams & Wilkins Co. Vol. 66, No.1 Printed in U.S.A. CASE REPORTS GASTRIC HETEROTOPIA IN THE ILEUM WITH ULCERATION AND CHRONIC BLEEDING KARIM

More information

Endoscopic atrophic classification before and after H. pylori eradication is closely associated with histological atrophy and intestinal metaplasia

Endoscopic atrophic classification before and after H. pylori eradication is closely associated with histological atrophy and intestinal metaplasia E311 before and after H. pylori eradication is closely associated with histological atrophy and intestinal metaplasia Authors Institution Masaaki Kodama, Tadayoshi Okimoto, Ryo Ogawa, Kazuhiro Mizukami,

More information

HISTOPATHOLOGICAL EVALUATION OF H. PYLORI ASSOCIATED GASTRIC LESIONS IN BENIN CITY, NIGERIA

HISTOPATHOLOGICAL EVALUATION OF H. PYLORI ASSOCIATED GASTRIC LESIONS IN BENIN CITY, NIGERIA 408 East African Medical Journal December 2012 East African Medical Journal Vol. 89 No. 12 December 2012 HISTOPATHOLOGICAL EVALUATION OF H. PYLORI ASSOCIATED GASTRIC LESIONS IN BENIN CITY, NIGERIA M. O.

More information

Common Inflammatory Gastrointestinal Disorders: Endoscopic and Pathologic Correlations

Common Inflammatory Gastrointestinal Disorders: Endoscopic and Pathologic Correlations Common Inflammatory Gastrointestinal Disorders: Endoscopic and Pathologic Correlations Nicole C. Panarelli, M.D. Attending Pathologist Montefiore Medical Center Associate Professor of Pathology - Albert

More information

Duodenal histology, ulceration, and Helicobacter pylori in the presence or absence of non-steroidal

Duodenal histology, ulceration, and Helicobacter pylori in the presence or absence of non-steroidal 1162 Departments of Gastroenterology, A S Taha I Nakshabendi R I Russell Pathology, S Dahill F D Lee and Rheumatology, Royal Infirmary, Glasgow R D Sturrock Correspondence to: Dr A S Taha, Gastroenterology

More information

gastric carcinoma patients and in controls representing the population at large

gastric carcinoma patients and in controls representing the population at large Br. J. Cancer (1984), 49, 521-53 Age-related trends of gastritis and intestinal metaplasia in gastric carcinoma patients and in controls representing the population at large P. Sipponen1, M. Kekki2 & M.

More information

Clinical Study Status of the Gastric Mucosa with Endoscopically Diagnosed Gastrointestinal Stromal Tumor

Clinical Study Status of the Gastric Mucosa with Endoscopically Diagnosed Gastrointestinal Stromal Tumor Diagnostic and erapeutic Endoscopy, Article ID 429761, 5 pages http://dx.doi.org/10.1155/2014/429761 Clinical Study Status of the Gastric Mucosa with Endoscopically Diagnosed Gastrointestinal Stromal Tumor

More information

OPERATIVE TREATMENT OF ULCER DISEASE

OPERATIVE TREATMENT OF ULCER DISEASE Página 1 de 8 Copyright 2001 Lippincott Williams & Wilkins Greenfield, Lazar J., Mulholland, Michael W., Oldham, Keith T., Zelenock, Gerald B., Lillemoe, Keith D. Surgery: Scientific Principles & Practice,

More information

Original Article Increased lysozyme expression in gastric biopsies with intestinal metaplasia and pseudopyloric metaplasia

Original Article Increased lysozyme expression in gastric biopsies with intestinal metaplasia and pseudopyloric metaplasia www.ijcem.com/ijcem908003 Original Article Increased lysozyme in gastric biopsies with intestinal metaplasia and pseudopyloric metaplasia Carlos A Rubio, Ragnar Befrits Gastrointestinal and Liver Pathology

More information

Specimens of Gastric Cancer: A Preliminary Evaluation in

Specimens of Gastric Cancer: A Preliminary Evaluation in Diagnostic and Therapeutic Endoscopy, Vol. 4, pp. 35-42 Reprints available directly from the publisher Photocopying permitted by license only (C) 1997 OPA (Overseas Publishers Association) Amsterdam B.V.

More information

Digestive system L 2. Lecturer Dr. Firdous M. Jaafar Department of Anatomy/Histology section

Digestive system L 2. Lecturer Dr. Firdous M. Jaafar Department of Anatomy/Histology section Digestive system L 2 Lecturer Dr. Firdous M. Jaafar Department of Anatomy/Histology section objectives 1-Describe the general structure of digestive tract: a-mucosa. b-submucosa. c-muscularis externa d-adventitia

More information

Gastric mucosal status in patients with reflux esophagitis

Gastric mucosal status in patients with reflux esophagitis Gastric mucosal status in patients with reflux esophagitis Riyadh Mohamad Hasan 1, Batool Mutar Mahdi 2 1. Department of Surgery, Al-Kindy College of Medicine, University of Baghdad, Iraq 2. Department

More information

A PLACEBO CONTROLLED TRIAL OF BISMUTH SALICYLATE IN HELICOBACTER PYLORI ASSOCIATED GASTRITIS

A PLACEBO CONTROLLED TRIAL OF BISMUTH SALICYLATE IN HELICOBACTER PYLORI ASSOCIATED GASTRITIS A PLACEBO CONTROLLED TRIAL OF BISMUTH SALICYLATE IN HELICOBACTER PYLORI ASSOCIATED GASTRITIS Pages with reference to book, From 154 To 156 Javed Iqbal Kazi, Naeem Aon Jafarey, Syed Mahmood Alam ( Department

More information

Acid-Peptic Diseases of the Stomach and Duodenum Including Helicobacter pylori and NSAIDs Prof. Sheila Crowe

Acid-Peptic Diseases of the Stomach and Duodenum Including Helicobacter pylori and NSAIDs Prof. Sheila Crowe Acid-Peptic Diseases of the Stomach and Duodenum Including Helicobacter pylori and NSAIDs 1 Division of Gastroenterology UC San Diego School of Medicine Clinical presentations of Helicobacter pylori infection

More information

Gastrointestinal pathology 2018 lecture 4. Dr Heyam Awad FRCPath

Gastrointestinal pathology 2018 lecture 4. Dr Heyam Awad FRCPath Gastrointestinal pathology 2018 lecture 4 Dr Heyam Awad FRCPath Topics to be covered Peptic ulcer disease Hiatal hernia Gastric neoplasms Peptic ulcer disease (PUD)= chronic gastric ulcer Causes H pylori

More information

The value of serum pepsinogen levels for the diagnosis of gastric diseases in Chinese Han people in midsouth China

The value of serum pepsinogen levels for the diagnosis of gastric diseases in Chinese Han people in midsouth China Zhang et al. BMC Gastroenterology 2014, 14:3 RESEARCH ARTICLE Open Access The value of serum pepsinogen levels for the diagnosis of gastric diseases in Chinese Han people in midsouth China Xiao-mei Zhang

More information

Intestinal metaplasia and Helicobacter pylori: an

Intestinal metaplasia and Helicobacter pylori: an 16 Department of Internal Medicine, St Elisabeth's of Groote Gasthuis, Haarlem, The Netherlands M E Craanen W Dekker J Ferwerda Department of Pathology, Public Health Laboratory, Haarlem, The Netherlands

More information

Gastric adenocarcinoma of the

Gastric adenocarcinoma of the Comment From the Editors Spasmolytic Polypeptide- Expressing Metaplasia and Intestinal Metaplasia: Time for Reevaluation of Metaplasias and the Origins of Gastric Cancer Gastric adenocarcinoma of the intestinal

More information

Correlation Between Endoscopic and Histological Findings in Different Gastroduodenal Lesion and its Association with Helicobacter Pylori

Correlation Between Endoscopic and Histological Findings in Different Gastroduodenal Lesion and its Association with Helicobacter Pylori ORIGINAL ARTICLE Correlation Between Endoscopic and Histological Findings in Different Gastroduodenal Lesion and its Association with Helicobacter Pylori *A. Sultana 1, SM Badruddoza 2, F Rahman 3 1 Dr.

More information

GRANULOMATOUS COLITIS: SIGNIFICANCE OF INVOLVEMENT OF THE TERMINAL ILEUM

GRANULOMATOUS COLITIS: SIGNIFICANCE OF INVOLVEMENT OF THE TERMINAL ILEUM GASTROENTEROLOGY 64: 1071-1076, 1973 Copyright 1973 by The Williams & Wilkins Co. Vol. 64, No.6 Printed in U.S.A. GRANULOMATOUS COLITIS: SIGNIFICANCE OF INVOLVEMENT OF THE TERMINAL ILEUM JAMES A. NELSON,

More information

The effect of proton pump inhibitors on the gastric mucosal microenvironment

The effect of proton pump inhibitors on the gastric mucosal microenvironment Original papers The effect of proton pump inhibitors on the gastric mucosal microenvironment Yen-Chun Peng,,, A F, Lan-Ru Huang, A, C, E, Hui-Ching Ho, C, Chi-Sen Chang, C, E, Shou-Wu Lee, E, Ching-Chang

More information

MICROSTRUCTURES LIPS TOOTH TONGUE OESOPHAGUS STOMACH, CARDIAC, PYLORIC FUNDIC GLANDS

MICROSTRUCTURES LIPS TOOTH TONGUE OESOPHAGUS STOMACH, CARDIAC, PYLORIC FUNDIC GLANDS MICROSTRUCTURES LIPS TOOTH TONGUE OESOPHAGUS STOMACH, CARDIAC, PYLORIC FUNDIC GLANDS HUMAN ANATOMY: MICROSTRUCTURES CLASSIFICATION: LOCATION AND BOUNDARIES, FORM, FUNCTION, MICROSCOPIC STRUCTURE: A hollow

More information

Development of the Rodent Gastrointestinal Tract:

Development of the Rodent Gastrointestinal Tract: White Paper Development of the Rodent Gastrointestinal Tract: The regulation of the development of the GI tract is unique and complex. With respect to the GI tract there are several considerations that

More information

Serum pepsinogen I and pepsinogen II levels and its ratio in patients with gastric cancer: a case control study

Serum pepsinogen I and pepsinogen II levels and its ratio in patients with gastric cancer: a case control study International Surgery Journal Abraham A et al. Int Surg J. 2017 Jan;4(1):356-360 http://www.ijsurgery.com pissn 2349-3305 eissn 2349-2902 Original Research Article DOI: http://dx.doi.org/10.18203/2349-2902.isj20164469

More information

Pepsinogen I ELISA. For the quantitative determination of pepsinogen I in human serum. For Research Use Only. Not For Use In Diagnostic Procedures.

Pepsinogen I ELISA. For the quantitative determination of pepsinogen I in human serum. For Research Use Only. Not For Use In Diagnostic Procedures. Pepsinogen I ELISA For the quantitative determination of pepsinogen I in human serum Please read carefully due to Critical Changes, e.g., Standard Reagent Preparation. For Research Use Only. Not For Use

More information

Gastric and duodenal mucosa in 'healthy' individuals

Gastric and duodenal mucosa in 'healthy' individuals Journal of Clinical Pathology, 1978, 31, 69-77 Gastric and duodenal mucosa in 'healthy' individuals An endoscopic and histopathological study of 50 volunteers J. KREUNING1, F. T. BOSMAN2, G. KUIPER', A.

More information

Symptomatic significance of gastric mucosal changes

Symptomatic significance of gastric mucosal changes Gut, 1977, 18, 295-300 Symptomatic significance of gastric mucosal changes after surgery for peptic ulcer A. M. HOARE, E. L. JONES, J. ALEXANDER-WILLIAMS, AND C. F. HAWKINS From the Queen Elizabeth Hospital,

More information

Relationship of Helicobacter pylori Infection with Gastric Black Spots Shown by Endoscopy

Relationship of Helicobacter pylori Infection with Gastric Black Spots Shown by Endoscopy doi: 10.2169/internalmedicine.1751-18 http://internmed.jp ORIGINAL ARTICLE Relationship of Helicobacter pylori Infection with Gastric Black Spots Shown by Endoscopy Kyoichi Adachi 1, Takumi Notsu 1, Tomoko

More information

Campylobacter like organisms on the gastric mucosa:

Campylobacter like organisms on the gastric mucosa: J Clin Pathol 1984;37:1002-1006 Campylobacter like organisms on the gastric mucosa: culture, histological, and serological studies DM JONES,* AM LESSELLS,t JOAN ELDRIDGE* From the *Public Health Laboratory

More information

H M T El-Zimaity, J Ramchatesingh, M Ali Saeed, D Y Graham

H M T El-Zimaity, J Ramchatesingh, M Ali Saeed, D Y Graham J Clin Pathol 2001;54:679 683 679 Papers Gastrointestinal Mucosa Pathology Laboratory, VA Medical Center and Baylor College of Medicine, Houston, Texas 77030, USA H M T El-Zimaity J Ramchatesingh D Y Graham

More information

High frequency of helicobacter negative gastritis

High frequency of helicobacter negative gastritis Gut 1996; 38: 379-383 High frequency of helicobacter negative gastritis in patients with Crohn's disease 379 L Halme, P Karkkainen, H Rautelin, T U Kosunen, P Sipponen Fourth Department of Surgery, Helsinki

More information

Assessment of symptomatic response as predictor of Helicobacter pylori status following eradication therapy in patients with ulcer

Assessment of symptomatic response as predictor of Helicobacter pylori status following eradication therapy in patients with ulcer 618 University Department of Medicine and Therapeutics, Western Infirmary, Glasgow G11 6NT, UK K E L McColl A El-Nujumi L S Murray E M El-Omar A Dickson A W Kelman T E Hilditch Correspondence to: Professor

More information

Helicobacter pylori:an Emerging Pathogen

Helicobacter pylori:an Emerging Pathogen Bacteriology at UW-Madison Bacteriology 330 Home Page Helicobacter pylori:an Emerging Pathogen by Karrie Holston, Department of Bacteriology University of Wisconsin-Madison Description of Helicobacter

More information

ENDOLUMINAL APPROACH FOR THE MANAGEMENT OF GASTROINTESTINAL CARCINOID

ENDOLUMINAL APPROACH FOR THE MANAGEMENT OF GASTROINTESTINAL CARCINOID ENDOLUMINAL APPROACH FOR THE MANAGEMENT OF GASTROINTESTINAL CARCINOID Manoop S. Bhutani, MD, FASGE, FACG, FACP, AGAF, Doctor Honoris Causa Professor of Medicine Eminent Scientist of the Year 2008, World

More information

Digestive System Module 4: The Stomach *

Digestive System Module 4: The Stomach * OpenStax-CNX module: m49286 1 Digestive System Module 4: The * Donna Browne Based on The by OpenStax This work is produced by OpenStax-CNX and licensed under the Creative Commons Attribution License 4.0

More information

MECHANISM BY WHICH FAT IN THE UPPER SMALL INTESTINE INHIBITS GASTRIC ACID

MECHANISM BY WHICH FAT IN THE UPPER SMALL INTESTINE INHIBITS GASTRIC ACID GASTROENTEROLOGY Copyright 1969 by The Williams & Wilkins Co. Vol. 56, No.3 Printea in U.S.A. MECHANISM BY WHICH FAT IN THE UPPER SMALL INTESTINE INHIBITS GASTRIC ACID H. T. DEBAS, M.D., B. S. BEDI, M.B.,

More information

Korean gastric cancer screening program, algorithms and experience.

Korean gastric cancer screening program, algorithms and experience. Korean gastric cancer screening program, algorithms and experience. Jun Haeng Lee, MD. Department of Medicine, Sungkyunkwan University School of Medicine, Seoul, Korea Today s topics Korean cancer screening

More information

Immunoglobulin G Antibody against Helicobacter pylori: Clinical Implications of Levels Found in Serum

Immunoglobulin G Antibody against Helicobacter pylori: Clinical Implications of Levels Found in Serum CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, Sept. 2002, p. 1044 1048 Vol. 9, No. 5 1071-412X/02/$04.00 0 DOI: 10.1128/CDLI.9.5.1044 1048.2002 Copyright 2002, American Society for Microbiology. All Rights

More information

ORIGINAL ARTICLE ROLE OF H. PYLORI IN PATIENTS OF GASTRIC CANCER IN SOUTHERN ODISHA

ORIGINAL ARTICLE ROLE OF H. PYLORI IN PATIENTS OF GASTRIC CANCER IN SOUTHERN ODISHA ROLE OF H. PYLORI IN PATIENTS OF GASTRIC CANCER IN SOUTHERN ODISHA Kalandi Barik 1, I.C. Muduli 2, S.N. Mallick 3,Lachhaman Bag 4, Anower Hossen Halder 5, Rupesh Sondawle 6, Sarada Prasanna Sahoo 7, Sanjit

More information

Cancer of the Stomach

Cancer of the Stomach Cancer of the Stomach Review of Consecutive Ten Year Intervals KENNETH ADASHEK, M.D.,* JAMES SANGER, M.D.,t WILLIAM P. LONGMIRE, JR., M.D.* Records were reviewed for all patients who underwent primary

More information

Cholecystectomy and duodenogastric reflux: interacting effects over the gastric mucosa

Cholecystectomy and duodenogastric reflux: interacting effects over the gastric mucosa DOI 10.1186/s40064-016-3641-z RESEARCH Open Access Cholecystectomy and duodenogastric reflux: interacting effects over the gastric mucosa Erdinc Mercan 1, Ugur Duman 1, Deniz Tihan 1, Evren Dilektasli

More information

Endoscopic Corner CASE 1. Sirimontaporn N Klaikaew N Imraporn B Rerknimitr R

Endoscopic Corner CASE 1. Sirimontaporn N Klaikaew N Imraporn B Rerknimitr R Endoscopic Corner Sirimontaporn N, et al. THAI J GASTROENTEROL 2010 Vol. 11 No. 3 Sept. - Dec. 2010 171 Sirimontaporn N Klaikaew N Imraporn B Rerknimitr R CASE 1 A 47- year-old female presented to the

More information

T he secretion of acid is an important function of the

T he secretion of acid is an important function of the 927 ORIGINAL ARTICLE Gastrin (G) cells and somatostatin (D) cells in patients with dyspeptic symptoms: Helicobacter pylori associated and non-associated gastritis Y Liu, G D C Vosmaer, G N J Tytgat, S-d

More information

Risk Factors for Gastric Tumorigenesis in Underlying Gastric Mucosal Atrophy

Risk Factors for Gastric Tumorigenesis in Underlying Gastric Mucosal Atrophy Gut and Liver, Vol. 11, No. 5, September 2017, pp. 612-619 ORiginal Article Risk Factors for Gastric Tumorigenesis in Underlying Gastric Mucosal Atrophy Ji Hyun Song 1, Sang Gyun Kim 2, Eun Hyo Jin 1,

More information

In 1998, the American College of Gastroenterology issued ALIMENTARY TRACT

In 1998, the American College of Gastroenterology issued ALIMENTARY TRACT CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2012;10:1232 1236 ALIMENTARY TRACT Effects of Dropping the Requirement for Goblet Cells From the Diagnosis of Barrett s Esophagus MARIA WESTERHOFF,* LINDSEY HOVAN,

More information

New developments in pathogenesis, gastric cancer. Matthias Ebert. II. Medizinische Klinik Klinikum rechts der Isar TU München

New developments in pathogenesis, gastric cancer. Matthias Ebert. II. Medizinische Klinik Klinikum rechts der Isar TU München New developments in pathogenesis, diagnosis, therapy and prevention of gastric cancer Matthias Ebert II. Medizinische Klinik Klinikum rechts der Isar TU München Gastric Cancer Pathogenesis Diagnosis Treatment

More information

Helicobacter Pylori Infection Can Be Linked to Low Levels of Serum Cobalamins

Helicobacter Pylori Infection Can Be Linked to Low Levels of Serum Cobalamins Australian Journal of Basic and Applied Sciences, 3(3): 1898-1902, 2009 ISSN 1991-8178 Helicobacter Pylori Infection Can Be Linked to Low Levels of Serum Cobalamins 1,4 2 3 4 Jamil R. AL-Alami; Kamal Bani-Hani;

More information

3, 4), although its concentration in mixed gastric

3, 4), although its concentration in mixed gastric THE VALUE OF THE ACID TEST MEAL: A STUDY OF NORMAL PERSONS AND OF PERSONS WITH DUODENAL ULCER By C. STUART WELCH AND MANDRED W. COMFORT (From The Mayo Foundation and the Division of Medicine, The Mayo

More information

Natural history of chronic gastritis in a populationbased

Natural history of chronic gastritis in a populationbased Scandinavian Journal of Gastroenterology ISSN: 0036-5521 (Print) 1502-7708 (Online) Journal homepage: http://www.tandfonline.com/loi/igas20 Natural history of chronic gastritis in a populationbased cohort

More information

Commonly Encountered Neuro-Endocrine Tumors of the Gut

Commonly Encountered Neuro-Endocrine Tumors of the Gut Commonly Encountered Neuro-Endocrine Tumors of the Gut Moderators: Giuseppe Aliperti, MD Steven Edmundowicz, MD Panelists Douglas O. Faigel, MD Professor of Medicine Department of Gastroenterology Oregon

More information

Gastricsin in the benign and malignant prostate

Gastricsin in the benign and malignant prostate J Clin Pathol 1985;38:639-643 Gastricsin in the benign and malignant prostate WA REID,* CN LIDDLE,t J SVASTI,t J KAY From the *Department ofpathology, University of Leeds, Leeds, the tdepartment ofpathology,

More information

Mucus, pepsin, and peptic ulcer

Mucus, pepsin, and peptic ulcer Leading articles Mucus, pepsin, and peptic ulcer Gut, 1986, 27, 233-238 In spite of a vast amount of research we still do not know the cause of chronic peptic ulceration. It is generally agreed that the

More information